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A t p H 7.8 the dithranol anion la is oxidized in the dark to yield the bianthrone 3 besides dithranol brown, 
whilst 0 2 is reduced to 02" and H 2 0 2 . 0 2 ' ~ was detected by the reduction of nitroblue-tetrazolium 
(NBT, 4). The formation of the formazan 5 was inhibited by superoxide dismutase (SOD). Exclusion of 
0 2 and addition of S O D reveal a direct electron transfer from la to 4 and to cytochrome c which was not 
affected in the presence of S O D . - In vivo experiments indicate a low rate of lipid peroxidation which 
was determined on the basis of ethane exhalation. 
Bildung aktiver Sauerstoffspezies durch Dithranol, 3. Mittl.1»: Dithranol, aktive Sauerstoffspezies und 
Lipidperoxidation in vivo 
Dithranolanion (la) wird bei p H 7.8 unter Lichtausschluß zum Bianthron 3 und zu Dithranolbraun oxi-
diert, während 0 2 zu 0 2 ~ und H 2 0 2 reduziert wird. 0 2 ~ wurde durch Reduktion von Nitrotetrazolium-
blau (NBT, 4) nachgewiesen, die Bildung des Formazans 5 wurde durch Superoxid Dismutase (SOD) ge-
hemmt. 0 2 -Aussch luß und Zugabe von S O D weisen einen direkten Elektronentransfer von la auf 4 bzw. 
Cytochrom c nach, der in Gegenwart von S O D nicht beeinträchtigt wurde. - In v/vo-Experimente weisen 
auf eine geringfügige Lipidperoxidation hin, die über die Ethanausatmung gemessen wurde. 
According to Gollnick1^ photooxygenations are classified as type I- and type Il-processes. Type I pro-
cesses are characterized as reactions of the sensitizer in the excited state either with ground state oxygen 
( 3 0 2 ) or with the reactant via electron transfer, whilst type II reactions produce oxygen in an excited state 
( 1 0 2 ) 3 ) . We have shown that the antipsoriatic compound dithranol (1) produces *0 2 , the main product of 
this type II process being chrysazin (2) 1» 4). In the dark, however, only the bianthrone 3 and the so called 
dithranol brown arise. In both cases, 1-anion is attacked by 0 2 . Mustakallio et al.5> have found a radical 
by ESR-spectroscopy, which was identified as l,8-dihydroxy-9-anthrone-10-yl-radical (lb) by Davies6^. 
One electron oxidation of la should lead, therefore, to superoxide-radical-anion 0 2 ' ~ by electron transfer 
from la to 3 0 2 (scheme 1). 
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Amoung various tests for 02'7\ N B T (4)8>9) turned out to be useful for our experiments because its 
reduced form 5 (X max = 560 nm 1 0)) does not interfere with the absorption of la in aqueous buffer 1 1 ) (pH 
= 7.8: X max = 384 nm). 
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Results 
After a steep rise at the beginning, 1 reduces 4 to the corresponding diformazan 5 
steadily (fig. 1). Therfore, the reduction rate was determined at 560 nm after this initial 
phase. As it is shown in fig. 2, the rate of formation of 5 is a linear function of the con-
centration of 1. 
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Fig. 1: Time course of the reduction of N B T in the presence of dithranol • 0 2 ; O A r 
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Fig. 2: Rate of reduction of N B T as a function of dithranol-concentration 
Control experiments under N 2 and Ar , however, show that 4 is reduced not only by 
0 2 ~ , but also by a direct electron transfer from la to 4 under anaerobic conditions. As 
to specify the identification of 0 2 * the experiments were repeated in the presence of 
SOD. This enzyme accelerates the conversion of 0 2 '~ (eq. 4, see below) at p H 7.4 by a 
factor 104 as compared to the spontaneous dismutation12). - We standardized the con-
centration of 1 so that the increase of absorption at 560 nm became 0.012/min (fig. 2). 
Fig. 3 shows that the reduction of 4 to 5 is lowered down by SOD to 55 %, indicating 
that this reduction is provoked by 0 2 " to this extent. This inhibition does not depend 
on whether the enzyme is added before or during the reaction (fig. 4). 
Further control experiments were run by adding SOD to N B T and 1 under N 2 and 
testing the influence of desactived SOD (100°, 5 min) on the system l / N B T / 0 2 : in both 
cases the curves correspond to fig. 1, indicating that there are no inhibitory effects ei-
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Fig. 3: Inhibition of N B T reduction by S O D in the system dithranol/0 2 
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Fig. 4: Reduction of N B T in the presence of dithranol • without S O D ; A S O D (75 ug) was added after 
3 min; O S O D (75 jag) was added before the reaction 
ther by SOD under anaerobic conditions or by the desactivated enzyme. Therefore, an 
interference of traces of oxygen is excluded which could influence the formation of 5 
catalytically via the recyclic system of equations 2 and 3 with la as the ultimate elec-
tron source: 
4 l a + N B T > 4 l b + 5 (eq. 1) 
l a + 0 2 > l b + 0 2 ' ~ (eq.2) 
4 O 2 ' ~ + N B T + 2 H 0 > 5 +4 0 2 (eq. 3) 
O 2 - - + O 2 - - + 2 H 0 > 0 2 + H 2 0 2 (eq.4) 
Under anaerobic conditions N B T is reduced only according to eq. 1. Obviously 
(fig. 1) this direct electron transfer is favoured over the 0 2 mediated formation of 5. 
As an additional test for 0 2 ~ we used the reduction of cytochrome c 1 3 ) ; this reaction 
is very much faster than the reduction of N B T : after 15 min the reduction was comple-
te and it was scarcely influenced by SOD. This result corresponds to those of 
other groups, who - contrary to N B T - did not observe an inhibition of cytochrome c 
reduction by SOD, testing the 0 2 '"-producing systems phenazine methosulfate/ 
N A D H 1 4 ' 1 5 ) or flavine nucleotid/NADH 1 6 ) , respectively. 
The type II product chrysazin (2) does not reduce N B T , 3 shows a very weak effect. 
Because 0 2 ~ dismutates rapidly, the formation of H 2 0 2 in the system l / 0 2 was con-
ceivable, at least as a secondary product. Unnaxl) has already found this active oxygen 
species (KI/starch; benzidine-reaction) when he examined the hypothesis that 1 
(Cignolin) practises its efficacy via H 2 0 2 . We identified H 2 0 2 by a modified Fe(III)-
thiocyanate test (A, max = 480 nm) 1 8 ). 
The formation of active oxygen species and of the dithranol radical lb 5' 6 ) points to-
wards lipid peroxidation by 1. lb is known to catalyze the UV-induced peroxidation of 
epidermis lipids 1 9 ). *0 2 converts polyunsaturated fatty acids (PUFAHs) to lipidperoxi-
des via a non-radical mechanism20), in a model experiment we have shown that hydro-
peroxides of unsaturated fatty acids are formed by la, acting as a photosensitizer4). 
On the contrary, H 2 0 2 does not provoke lipid peroxidation in biomembranes21) and 
02*~ does not react with P U F A H s 2 2 ) ; according to Haber-Weiß23) or by a modified 
Haber-Weiß-reeLCtion24~26\ however, the very reactive ' O H is formed so that H 2 0 2 and 
0 2 ~ can lead to lipid peroxidation indirectly. - The formation of alkanes, mainly 
ethane and pentane, is the most reliable index for lipid peroxidation in vivo and in 
vitro21\ Ethane is formed from co-3-unsaturated fatty acids 2 8 ); the quantity of ethane 
corresponds to the degree of peroxidation, the determination of exhaled alkanes is ge-
nerally used for quantifying the lipid peroxidation in vivo29~32\ We used the device deve-
loped by Siegers et a l . 3 0 ) for CCl 4-exposition (Table 1): 
Table 1: Ethane exhaled (nmol/kg body weight) after cutane-
ous application of 10 ml/kg body weight. Results are 
expressed as means and their standard errors of three 
experiments. 
t [min] Dithranol, 2 % 
in Olive oi l 
Olive o i l 
(controls) 
30 7.1 ± 0 . 6 2.9 ± 1 . 0 
60 8.2 ± 0 . 6 3.6 ± 0 . 6 
90 9.3 ± 0 . 6 5.8 ± 1 . 0 
120 10.2 ± 0 . 5 5.2 ± 1 . 0 
After cutaneous application of 1 in olive-oil the exhaled ethane is twice as high as in 
the control animals, nevertheless the values are far below those of substances well 
known for their efficacy in lipid peroxidation (under identical conditions CC1 4 leads to 
39.6 ± 4.1 nmol C 2 H 6 after 2 h 3 2 )). 
Discussion 
Fig. 5 gives a comprehensive view of 1-dependent oxygen activation. Because ' O H 
can result from *0 2 , 0 2 '~ and H 2 0 2 via secondary reactions 2 3 _ 2 6 ), a lot of biological ef-
fects are conceivable33). 
HYDROGEN H 2 0 2 
PEROXIDE 
MOD1F 
HABER-WEISS 
REACTION 
DITHRANOlrANlON 
Fe 3 + 'Oö SUPEROXIDE DITHRANOL CHRYSAZIN 'o, 
f V ^ i n N L R A D I C A L SINGLET H V ANION OXYGEN 
BIANTHRONE 
IPh 178.51 
OHVOH 
HYDROXYL. 
RADICAL BIOLOGICAL EFFECTS 
The importance of active oxygen species for antipsoriatic efficacy is significantly de-
monstrated: 102 and 0 2 are generated by psoralenes34); coal tar which is still used as 
an antipsoriatic remedy contains photosensitizers3). Considering the targets of the ac-
tive oxygen species mentioned above, the various antipsoriatic effects of l 3 5 , 3 6 ) c a n be 
summarized as in fig. 6. 
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BIOLOGICAL E F F E C T S 
OF 
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Antipsoriaiic Efficacy 
Side Effects 
Side effects by lipid peroxidation are unlikely in the modern "minutes-therapy"3 7 ), 
when 1 is applied in high concentrations only for 20 min; lipid peroxidation can not be 
excluded a priori for the combined regimen 1 + UV-light (Ingram), because an increas-
ed formation of l 0 2 is conceivable (la is a photosensitizer4)). Moreover, lipid peroxida-
tion is stimulated by U V light 1 8 , 3 8 , 3 9 ) and by visible light in the presence of photo-
sensitizers40). 
Experimental Part 
UV-spectroscopy: Shimadzu 210; Uvikon 810 (Kontron) with Uvikon recorder 21 and thermostatized cell 
holder; pathlenght 10 mm, vol. 3.0 ml, temp. 25°. - Gas chromatography: Fractovap 4200, Carlo Erba. -
Chemicals: Nitrobluetetrazolium (NBT, 4): Merck; Superoxide dismutase (EC 1.15.1.1.) type I from bo-
vine blood: Sigma; cytochrome c type III from horse heart: Sigma; 1.8-dihydroxy-9.10-anthraquinone 
(chrysazin, 2): Synochem; 1.8-dihydroxy-9-anthrone (dithranol, 1) and 1.1'.8.8'-tetrahydroxy-10.10'-
bisanthrone: lit.41), purification by column chromatography (Si0 2/CH 2C1 2). 
Stock solutions: 
1: 4.52 mg (0.02 mmol) were dissolved in 10.00 ml EtOH and kept under N 2 in the dark. - NBT: 40.9 mg 
(0.05 mmol) in 10.00 ml EtOH, N 2 , dark. - Buffer: 11.41 g K 2 H P 0 4 • 3H 2 0 (0.05 mol) and 0.68 g 
K H 2 P 0 4 (0.005 mol) in ca. 800 ml bidist. water were adjusted to pH 7.8 with 0.1 N-NaOH and filled up 
to 1000.0 ml with bidist. water. - Superoxide dismutase: 3.75 mg enzyme (2800 units/mg protein) in 
5.00 ml buffer. - Cytochrome c: 18.6 mg (1.5 umol) in 5.00 ml EtOH/buffer (l:l-vol.). 
Identification of 02" 
NBT-conc: 1.67 • 10~4 M (100 ul stock solution). The reduction product 5 is nearly insoluble in water; at 
this cone, precipitation of 5 is avoided10). 1-conc: 3.33 • 10 5 M - 1.67 • 10 4 M (50-250 ul stock solu-
tion). The mixture of NBT and 1 was made up to 3.00 ml with buffer and saturated with 0 2 , N 2 or Ar, re-
spectively. In the case of SOD experiments, 7.5-225 ug (10-300 ul stock solution) were added before fil-
ling up. The velocity of the formation of 5 was determined at 560 nm. - The cytochrome c reduction was 
followed at 550 nm with a cytochrome cone. 2 • 10~5 (200 ul stock solution). 
Identification of H202 
22.6 mg (0.1 mmol) 1 in 10 ml acetone saturated with 0 2 , and 2 drops saturated Ba(OH)2 were shaken at 
r.t. for 2 h. After addition of 5 drops 5 N - H 2 S 0 4 the mixture was filtered, 0.2 ml 10 mM-(NH 4) 2Fe(S0 4) 2 
and 0.1 ml 2.5 M - K S C N were added to 3.0 ml filtrate. The mixture became red, X max = 480 nm. 
In vivo test of lipid peroxidation 
Male NMRI mice were shaved on the back. Approximately 0,3-0.4 ml of 200 mg 1 in 10 ml olive-oil 
(~ 200 mg/kg) were applied over an area of 2 x 2 cm. Immediately after application 4 mice were transfer-
red to a gas-tight closed system30) and the exhaled ethane was measured: from 3 parallel experiments 7 ml 
gas samples were taken via a rubber septum in 30 min intervals using a gas-tight syringe. The gas samples 
were injected into a sample loop of the gas Chromatograph. - column: Porapack Q (80/100 mesh), 3 m, 
temp. 90°. - detector: FID, temp. 170°. - N2-flow rate: 60 ml/min. - H2-flow rate: 20 ml/min. - Flow rate 
of synthetic air: 200 ml/min. Standardization by 0.25 ppm ethane in N 2 . - Retention time for C 2 H 6 under 
these conditions: 75 sec2 7'3 2). 
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